Elicio Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ELTX and other ETFs, options, and stocks.About ELTX
Elicio Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of cancer immunotherapies. It focuses on its Amphiphile platform for trafficking lymph nodes.
CEORobert T. Connelly
CEORobert T. Connelly
Employees32
Employees32
HeadquartersBoston, Massachusetts
HeadquartersBoston, Massachusetts
Founded2011
Founded2011
Employees32
Employees32
ELTX Key Statistics
Market cap140.35M
Market cap140.35M
Price-Earnings ratio-2.36
Price-Earnings ratio-2.36
Dividend yield—
Dividend yield—
Average volume104.76K
Average volume104.76K
High today$8.45
High today$8.45
Low today$7.92
Low today$7.92
Open price$8.36
Open price$8.36
Volume73.98K
Volume73.98K
52 Week high$12.62
52 Week high$12.62
52 Week low$4.60
52 Week low$4.60
Stock Snapshot
The current Elicio Therapeutics(ELTX) stock price is $8.00, with a market capitalization of 140.35M. The stock trades at a price-to-earnings (P/E) ratio of -2.36.
On 2025-12-06, Elicio Therapeutics(ELTX) stock traded between a low of $7.92 and a high of $8.45. Shares are currently priced at $8.00, which is +1.0% above the low and -5.3% below the high.
The Elicio Therapeutics(ELTX)'s current trading volume is 73.98K, compared to an average daily volume of 104.76K.
In the last year, Elicio Therapeutics(ELTX) shares hit a 52-week high of $12.62 and a 52-week low of $4.60.
In the last year, Elicio Therapeutics(ELTX) shares hit a 52-week high of $12.62 and a 52-week low of $4.60.
People also own
Based on the portfolios of people who own ELTX. This list is generated using Robinhood data, and it’s not a recommendation.